MRK analyst estimates
Merck (MRK) analyst ratings, the average price target and its range, and every firm's latest call.
MRK analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | KeyBanc | Merck (MRK) PT Raised to $165 at BofA Securities | $165.00 |
| Oct 30, 2026 | Guggenheim | Merck (MRK) PT Raised to $171 at Guggenheim | $171.00 |
| Oct 26, 2026 | Barclays | Merck price target raised to $180 from $150 at Barclays | $180.00 |
| Oct 22, 2026 | Wells Fargo | Merck intismeran data concerns look 'overdone,' says Wells Fargo | $165.00 |
| Oct 19, 2026 | Goldman Sachs | Merck price target lowered to $155 from $160 at Goldman Sachs | $155.00 |
| Oct 12, 2026 | RBC Capital | Merck (MRK) PT Lowered to $145 at RBC Capital | $145.00 |
| Oct 8, 2026 | Cantor Fitzgerald | Merck (MRK) PT Raised to $145 at Cantor Fitzgerald - Outstanding ESMO Expected | $145.00 |
| Sep 29, 2026 | Scotiabank | Merck price target raised to $180 from $155 at Scotiabank | $180.00 |
| Sep 11, 2026 | Berenberg Bank | Merck (MRK) PT Raised to $137 at Berenberg | $137.00 |
| Sep 10, 2026 | HSBC | Merck price target raised to $172 from $150 at HSBC | $172.00 |
| Sep 9, 2026 | Leerink Partners | Merck price target raised to $161 from $127 at Leerink | $161.00 |
| Sep 8, 2026 | Guggenheim | Merck (MRK) PT Raised to $170 at Guggenheim | $170.00 |
| Sep 4, 2026 | Wells Fargo | Merck price target raised to $170 from $150 at Wells Fargo | $170.00 |
| Aug 25, 2026 | Wolfe Research | Merck price target raised to $180 from $155 at Wolfe Research | $180.00 |
| Aug 25, 2026 | Argus Research | Merck price target raised to $170 from $145 at Argus | $170.00 |
- 21 firms rate MRK: 16 buy, 5 hold, 0 sell.
- The average price target is $163.54 from 13 analysts, from $137.00 to $180.00.
Updated 2026-11-02 17:53 UTC